United States · FDA National Drug Code directory
Risperidone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63304-950_8c155c45-e5c8-4358-90da-8f6d193ad88b
- Product NDC
- 63304-950
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Risperidone
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100806
- Source listing expiry
- 20261231
Source-listed ingredients
- RISPERIDONE — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63304-950-05) · 63304-950-05
- 10 POUCH in 1 BOX, UNIT-DOSE (63304-950-17) / 1 TABLET, ORALLY DISINTEGRATING in 1 POUCH (63304-950-11) · 63304-950-17
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63304-950-30) · 63304-950-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →